The c-Myc target gene network

Dang, Chi V., O’Donnell, Kathryn A., Zeller, Karen I., Nguyen, Tam, Osthus, Rebecca C., Li, Feng·2006·Seminars in Cancer Biology

Cited by (1,000)

Items 801–900 of 1,000

  1. Regulatory network analysis of microRNAs and genes in imatinib-resistant chronic myeloid leukemia
    Ismael Soltani, Hanen Gharbi, Islem Ben Hassine, Ghada Bouguerra, Kaïs Douzi, Mouheb Teber, Salem Abbès, Samia Menif · 2016 · Functional & Integrative Genomics
  2. The Effect of Glut1 and c-myc on Prognosis in Esophageal Squamous Cell Carcinoma of Kazakh and Han Patients
    Yaxing Zhou, Keming Zhou, Qian Liu, Hui Wang, Wen Wang, Yi Shi, Yuqing Ma · 2018 · Future Oncology
  3. Enhanced nuclear delivery of H1-S6A, F8A peptide by NrTP6-modified polymeric platform
    Dandan Xie, Fengling Wang, Yucheng Xiang, Yuan Huang · 2020 · International Journal of Pharmaceutics
  4. Multifunctionalized Protein-Based Drug Delivery System for Inhibition of Tumor Growth and Progression
    Yin Qin, Lei Xu, Yingying Guan, Hong Liu · 2020 · ACS Applied Bio Materials
  5. CDK7-dependent transcriptional addiction in bone and soft tissue sarcomas: Present and Future
    Jin Yuan, Xiaoyang Li, Shengji Yu · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  6. The Role of NOTCH1, GATA3, and c-MYC in T Cell Non-Hodgkin Lymphomas
    Mutaz Jamal Al‐Khreisat, Faezahtul Arbaeyah Hussain, Ali Abdelfattah, Alhomidi Almotiri, Ola M. Al-Sanabra, Muhammad Farid Johan · 2022 · Cancers
  7. Insights into the molecular mechanisms of pesticide tolerance in the Aporrectodea caliginosa earthworm
    Audrey Barranger, Christophe Klopp, Barbara Le Bot, Gaëlle Saramito, Lise Dupont, Stéphanie Llopis, Claudia Wiegand, Françoise Binet · 2022 · Environmental Pollution
  8. Nuclear Proteome Analysis of Monkey Embryonic Stem Cells During Differentiation
    Davood Nasrabadi, Mehran Rezaei Larijani, Ali Fathi, Hamid Gourabi, Ahmad Vosough, Hossein Baharvand, Ghasem Hosseini Salekdeh · 2010 · Stem Cell Reviews and Reports
  9. Targeted repression of AXIN2 and MYC gene expression using designer TALEs
    Sherri A. Rennoll, Samantha A. Scott, Gregory S. Yochum · 2014 · Biochemical and Biophysical Research Communications
  10. Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer
    Malihea Khaleghian, Issa Jahanzad, Abbas Shakoori, Àmirnader Emami Razavi, Cyrus Azimi · 2015 · Iranian Red Crescent Medical Journal
  11. Crosstalk between E2f1 and c-Myc mediates hepato-protective effect of royal jelly on taxol-induced damages
    Hassan Malekinejad, M Fani, S Kh Shafiee-Roodbari, Fatemeh Delkhosh-Kasmaie, Ali Rezaei-Golmisheh · 2016 · Human & Experimental Toxicology
  12. Lysine-52 stabilizes the MYC oncoprotein through an SCFFbxw7-independent mechanism
    Jason De Melo, S S Kim, Corey Lourenco, Linda Z. Penn · 2017 · Oncogene
  13. Sfp1 links TORC1 and cell growth regulation to the yeast SAGA‐complex component Tra1 in response to polyQ proteotoxicity
    Yuwei Jiang, Matthew D. Berg, Julie L. Genereaux, Khadija Ahmed, Martin L. Duennwald, Christopher J. Brandl, Patrick Lajoie · 2019 · Traffic
  14. FGFR1 is associated with c‐MYC and proangiogenic molecules in metastatic renal cell carcinoma under anti‐angiogenic therapy
    Jee Young Park, Pil‐Jong Kim, Su‐Jin Shin, Jae‐Lyun Lee, Yong Mee Cho, Heounjeong Go · 2020 · Histopathology
  15. MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma
    Magretta Adiamah, Bethany Poole, Janet C. Lindsey, Sarah E. Kohe, Alaide Morcavallo, Florence Burté, Rebecca M. Hill, Helen Blair, Dean Thompson, Mankaran Singh et al. · 2024 · Neuro-Oncology
  16. Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy
    Laura Grunewald, Lena Andersch, Konstantin Helmsauer, Silke Schwiebert, Anika Klaus, Anton George Henssen, Teresa Straka, Marco Lodrini, Sebastian G. Wicha, Steffen Fuchs et al. · 2025 · Pharmacological Research
  17. MYC at the tumor–immune interface: mechanisms of immune escape and immunotherapy resistance
    Íñigo González-Larreategui, M. C. Martin, Sílvia Casacuberta‐Serra, Laura Soucek · 2026 · Frontiers in Immunology
  18. Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer
    Yasmin M. Attia, Salama A. Salama, Samia A. Shouman, Cristina Ivan, Abdelrahman M. Elsayed, Paola Amero, Cristian Rodriguez‐Aguayo, Gabriel Lopez‐Berestein · 2022 · Pharmacological Reports
  19. Complex aneuploidy triggers autophagy and p53-mediated apoptosis and impairs the second lineage segregation in human preimplantation embryos
    Marius Regin, Yingnan Lei, Edouard Couvreu de Deckersberg, Charlotte Janssens, Anfien Huyghebaert, Yves Guns, Pieter Verdyck, Greta Verheyen, H. Van de Velde, Karen Sermon et al. · 2024 · eLife
  20. c-Myc-induced long noncoding RNA MIRE cooperates with hnRNPK to stabilize ELF2 mRNA and promotes clear cell renal cell carcinogenesis
    Bingyan Li, Bo Yao, Xiaorui Guo, Zhongyu Wang, Wei Xie, Xianning Wu, Fang Wang, Yide Mei · 2023 · Cancer Gene Therapy
  21. Targeting protein synthesis pathways in MYC-amplified medulloblastoma
    Devendra Kumar, Ranjana Kumari Kanchan, Nagendra K. Chaturvedi · 2025 · Discover Oncology
  22. Histone H2AX suppresses translocations in lymphomas ofEμ-c-Myctransgenic mice that contain a germline amplicon of tumor-promoting genes
    Angela M. Fusello, Julie E. Horowitz, Katherine S Yang-Iott, Brenna L. Brady, Bu Yin, Marta A. W. Rowh, Eric F. Rappaport, Craig H. Bassing · 2013 · Cell Cycle
  23. Evaluation of the prognostic importance of c-myc and bcl-2 expressions and the presence of epstein-barr virus in classical hodgkin lymphoma
    Aydan Kılıçarslan, VEDİA ÖZTÜRK, Aysun Şentürk Yıkılmaz, Mehmet Doğan, Mesut Akyol · 2018 · Turkish Journal of Pathology
  24. The biological effect and mechanism of the Wnt/β‑catenin signaling pathway on malignant melanoma A375 cells
    Yuxia Lin, Fangfei Wang, Qingfei Xing, Feng Guo, Mengzhen Wang, Yunjie Li · 2018 · Experimental and Therapeutic Medicine
  25. High MYC Levels Favour Multifocal Carcinogenesis
    Manuela Sollazzo, China Genchi, Simona Paglia, Simone Di Giacomo, Annalisa Pession, Dario de Biase, Daniela Grifoni · 2018 · Frontiers in Genetics
  26. Genome-wide promoter DNA methylation profiling of hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice
    Ramesh C. Kovi, Sachin Shivling Bhusari, Deepak Mav, Ruchir Shah, Thai Vu Ton, Mark James Hoenerhoff, Robert C. Sills, Arun R. Pandiri · 2019 · Archives of Toxicology
  27. Identification and Functional Characterization of Novel MYC-Regulated Long Noncoding RNAs in Group 3 Medulloblastoma
    Jessica N. Rea, Annamaria Carissimo, Daniela Trisciuoglio, Barbara Illi, Daniel J. Picard, Marc Remke, Pietro Laneve, Elisa Caffarelli · 2021 · Cancers
  28. MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma
    Rika Noji, Yoshihito Kano, Hideaki Hirai, Iichiroh Onishi, Naoto Nishii, Ryoichi Yoshimura, Satoshi Miyaké, Sadakatsu Ikeda, Hiroyuki Harada · 2021 · Oral Oncology
  29. Stabilization of the c-Myc Protein via the Modulation of Threonine 58 and Serine 62 Phosphorylation by the Disulfiram/Copper Complex in Oral Cancer Cells
    Gunng‐Shinng Chen, Ssu-Yu Chen, Shuting Liu, Cheng-Chih Hsieh, Shiao‐Pieng Lee, Shih‐Ming Huang · 2022 · International Journal of Molecular Sciences
  30. m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia
    Ya Liu, Yiying Chen, Maoping Cai, Yun‐Guang Hong, Xiang Wu, Songyu Li · 2023 · Aging
  31. Recombinant adenovirus‐mediated human telomerase reverse transcriptase gene can stimulate cell proliferation and maintain primitive characteristics in bovine mammary gland epithelial cells
    Xiaoying He, Yue‐Mao Zheng, Jie Lan, Yue‐Hong Wu, Jing Yan, Xiaoning He, Tuo Zhang, Yulong He, Yanling Zheng, Yong Zhang · 2011 · Development Growth & Differentiation
  32. MKK7γ1 reverses nerve growth factor signals: Proliferation and cell death instead of neuritogenesis and protection
    Wiebke Haeusgen, Thomas Herdegen, Vicki Waetzig · 2011 · Cellular Signalling
  33. Stem cells of GATA1-related leukemia undergo pernicious changes after 5-fluorouracil treatment
    加奈子 安部, Ritsuko Shimizu, Xiaoqing Pan, Hiromi Hamada, Hiroyuki Yoshikawa, Masayuki P. Yamamoto · 2009 · Experimental Hematology
  34. The role of molecular biology in the diagnosis of lymphoid neoplasms
    Marco Pizzi · 2014 · Frontiers in bioscience
  35. The Myc 3′ Wnt Responsive Element Regulates Neutrophil Recruitment After Acute Colonic Injury in Mice
    Wesley M. Raup‐Konsavage, Jennifer N. Roper, Faoud Terrence Ishmael, Gregory S. Yochum · 2013 · Digestive Diseases and Sciences
  36. RAFT Polymerization for the Synthesis of Tertiary Amine‐Based Diblock Copolymer Nucleic Acid Delivery Vehicles
    Annie K. McClellan, Taisen Hao, Tracy Ann Brooks, Adam E. Smith · 2017 · Macromolecular Bioscience
  37. Metabolomic profiling of mouse mammary tumor-derived cell lines reveals targeted therapy options for cancer subtypes
    Martin P. Ogrodzinski, Shao Thing Teoh, Sophia Y. Lunt · 2020 · Cellular Oncology
  38. MYC single-hit large B-cell lymphoma: clinicopathologic difference from MYC-negative large B-cell lymphoma and MYC double-hit/triple-hit lymphoma
    Yoon Ah Cho, Jiyeon Hyeon, Hyunwoo Lee, Junhun Cho, Seok‐Jin Kim, Won Seog Kim, Young Hyeh Ko · 2021 · Human Pathology
  39. High mitochondrial content is associated with breast cancer aggressiveness
    Patrick Lebok, Katharina S. Schütt, Martina Kluth, Isabell Witzel, Linn Lena Woelber, Peter Paluchowski, Luigi Terracciano, Christian Wilke, Uwe Heilenkötter, Volkmar Müller et al. · 2021 · Molecular and Clinical Oncology
  40. Getting MAD at MYC
    Maria Letizia Giardino Torchia, Jonathan D. Ashwell · 2018 · Proceedings of the National Academy of Sciences
  41. The 24-Hour Time Course of Integrated Molecular Responses to Resistance Exercise in Human Skeletal Muscle Implicates MYC as a Hypertrophic Regulator That is Sufficient for Growth
    Sebastian Edman, Ronald G. Jones, Paulo R. Jannig, Rodrigo Fernandez‐Gonzalo, Jessica Norrbom, Nicholas T. Thomas, Sabin Khadgi, Pieter Jan Koopmans, Francielly Morena da Silva, Calvin S. Peterson et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Oncogenic Control of Metabolism
    Natalya N. Pavlova, Craig B. Thompson · 2024 · Cold Spring Harbor Perspectives in Medicine
  43. Loss-of-function variants affecting the STAGA complex component SUPT7L cause a developmental disorder with generalized lipodystrophy
    Johannes Kopp, Leonard A. Koch, Hristiana Lyubenova, Oliver Küchler, Manuel Holtgrewe, Andranik Ivanov, Christèle Dubourg, Erika Launay, Sebastian Brachs, Stefan Mundlos et al. · 2024 · Human Genetics
  44. Regulation of c-Myc and NBS1 by ionizing radiation in glioblastoma cells
    Paulo M. G. Rodrigues, Roberto Salomon de Souza, Helena L. Borges, Rodrigo A. P. Martins · 2017 · Oncology Signaling
  45. Bromodomain Protein-directed Agents and MYC in Small Cell Lung Cancer
    Gerhard Hamilton, Sandra Stickler, Barbara Rath · 2024 · Current Cancer Drug Targets
  46. Expression of microRNA-155 in thalassemic erythropoiesis
    Tipparat Penglong, Nuttanan Pholngam, Nasra Tehyoh, Natta Tansila, Hansuk Buncherd, Supinya Thanapongpichat, Kanitta Srinoun · 2024 · PeerJ
  47. Myc on my mind: a transcription factor family's essential role in brain development
    Lori Anne Mainwaring, Bobby Bhatia, Anna Marie Kenney · 2010 · Oncotarget
  48. HLA Class II Defects in Burkitt Lymphoma: Bryostatin-1-Induced 17 kDa Protein Restores CD4+ T-Cell Recognition
    Azim Hossain, Jason M. God, Faisal F.Y. Radwan, Shereen Amria, Dan Zhao, Jennifer Rutherford Bethard, Azizul Haque · 2011 · Clinical and Developmental Immunology
  49. Exogenous c-Myc Blocks Differentiation and Improves Expansion of Human Erythroblasts In vitro
    Cristopher Geiler, Inez Andrade, Daniel Reif Greenwald · 2014 · International Journal of Stem Cells
  50. hTERT and TP53 deregulation in intestinal-type gastric carcinogenesis in non-human primates
    Mariana Ferreira Leal, Danielle Queiroz Calcagno, André Salim Khayat, Tanielly Cristina Raiol Silva, José Augusto Pereira Carneiro Muniz, Paulo Pimentel de Assumpção, Marı́lia de Arruda Cardoso Smith, Rommel Mário Rodríguez Burbano · 2012 · Clinical and Experimental Medicine
  51. Building Customizable Multisite‐Targeting c‐Myc shRNA Array into Branch‐PCR‐Constructed DNA Nanovectors for Enhanced Tumor Cell Suppression
    Longhuai Cheng, Dejun Ma, Liqing Lu, Di Ouyang, Zhen Xi · 2020 · ChemistrySelect
  52. Molecular genetic changes in gastric carcinoma
    Juhi M Singh, Puneet Kumar, Khushi Verma, Satyendra Kumar Tiwary, Gopeshwar Narayan, V.K. Dixit · 2020 · International Journal of Molecular and Immuno Oncology
  53. Salvianolic Acid B Noncovalently Interacts With Disordered c-Myc: A Computational and Spectroscopic-Based Study
    Ashutosh Kumar Singh, Ankur Kumar, Prateek Kumar, Taniya Bhardwaj, Rajanish Giri, Neha Garg · 2021 · Future Medicinal Chemistry
  54. One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies
    Antonia Kalushkova, Patrick Nylund, Alba Atienza Párraga, Andreas Lennartsson, Helena Jernberg‐Wiklund · 2021 · Epigenomes
  55. Construction of a Novel MYC-Associated ceRNA Regulatory Network to Identify Prognostic Biomarkers in Colon Adenocarcinoma
    Rui Xin, Xiao-Mei Tang, Ying‐Jie Jiang, Fei Yu, Sha Li, Chengyou Jia, Gao‐Ren Wang, Da Fu, Ji-Bin Liu, Yu‐Shui Ma · 2022 · Journal of Oncology
  56. The synthetic molecule stauprimide impairs cell growth and migration in triple-negative breast cancer
    Paloma Carrillo, Manuel Bernal, Clara Tellez-Quijorna, Ana Dácil Marrero, Isabel Vidal, Laura Castilla, Carlos Caro, Alejandro Domínguez, Maria Luisa García‐Martín, Ana R. Quesada et al. · 2022 · Biomedicine & Pharmacotherapy
  57. c-MYC-Induced AP4 Attenuates DREAM-Mediated Repression by p53
    Markus Kaller, Wenjing Shi, Heiko Hermeking · 2023 · Cancers
  58. Liver hyperplasia after tamoxifen induction of Myc in a transgenic medaka model
    Luciana Alcantarino Menescal, Cornelia Schmidt, Daniel Liedtke, Manfred Schartl · 2012 · Disease Models & Mechanisms
  59. Cilostazol reduces proliferation through c-Myc down-regulation in MDCK cells
    Balam Muñoz, Miriam Huerta, Esther López‐Bayghen · 2009 · European Journal of Pharmacology
  60. Nano-Assembly of Pamitoyl-Bioconjugated Coenzyme-A for Combinatorial Chemo-Biologics in Transcriptional Therapy
    Santosh Kumar Misra, Taylor L. Kampert, Dipanjan Pan · 2018 · Bioconjugate Chemistry
  61. G-quadruplex deconvolution with physiological mimicry enhances primary screening: Optimizing the FRET Melt2 assay
    Rhianna K. Morgan, Alexandra Maria Psaras, Quinea R. Lassiter, Kelsey Raymer, Tracy Ann Brooks · 2019 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  62. Profiling of Genetic Switches using Boolean Implications in Expression Data
    M. Volkan Çakır, Hans Binder, Henry Wirth · 2014 · Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics
  63. CXCL10 expression induced by Mxi1 inactivation induces mesangial cell apoptosis in mouse Habu nephritis
    Lingling Wu, Xiaoniao Chen, Yan Mei, Quan Hong, Zhe Feng, Yang Lv, Jun Wen, Xiaoluan Liu, Guangyan Cai, Xiangmei Chen · 2015 · Cellular Signalling
  64. c-myc rearrangement in B-cell lymphoblastic lymphoma with the involvement of multiple extranodal lesions
    Souichi Shiratori, Takeshi Kondo, Shinichi Fujisawa, Kanako Kubota, Mizuha Kosugi, Yusuke Shono, Junichi Sugita, Katsuya Fujimoto, Mitsufumi Nishio, Junji Tanaka et al. · 2011 · Leukemia & lymphoma/Leukemia and lymphoma
  65. c-Myc and Activated Ras During Skin Tumorigenesis: Cooperation at the Cancer Stem Cell Level?
    Andreas Trumpp · 2007 · Springer eBooks
  66. Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma
    Ekaterina Zhuravleva, Monika Lewińska, Colm J. O’Rourke, Antonio Pea, Asif Rashid, Ann W. Hsing, Andrzej Taranta, David Kuang-Fu Chang, Yu-Tang Gao, Jill E. Koshiol et al. · 2024 · Gut
  67. Salicylate-Elicited Activation of AMP-Activated Protein Kinase Directly Triggers Degradation of C-Myc in Colorectal Cancer Cells
    Ana Laura de Souza Almeida Matos, Ashley J. Ovens, Emil Jakobsen, Diego Iglesias‐Gato, Jacob Mathias Bech, Stine Friis, Lasse K. Bak, Gunvor Iben Madsen, Jonathan S. Oakhill, Pietri Puustinen et al. · 2025 · Cells
  68. Expression of β-Catenin and E-Cadherin, their Clinical Significance and Association with Complexity Index of Colon Carcinoma
    Abrar Ahmad, Victoria Hahn‐Strömberg · 2016 · Advancements in Genetic Engineering
  69. An in silico comparative transcriptome analysis identifying hub lncRNAs and mRNAs in brain metastatic small cell lung cancer (SCLC)
    Arsham Mikaeili Namini, Motahareh Jahangir, Maryam Mohseni, Ali‐Asghar Kolahi, Hossein Hassanian‐Moghaddam, Zeinab Mazloumi, Marzieh Motallebi, Mojgan Sheikhpour, Abolfazl Movafagh · 2022 · Scientific Reports
  70. MYCT1 in cancer development: Gene structure, regulation, and biological implications for diagnosis and treatment
    Jianan Xu, Yuanyuan Sun, Wei‐Neng Fu, Shuang Fu · 2023 · Biomedicine & Pharmacotherapy
  71. Large-Scale Alternative Polyadenylation-Wide Association Studies to Identify Putative Cancer Susceptibility Genes
    Xingyi Guo, Jie Ping, Yaohua Yang, Xinwan Su, Xiao‐Ou Shu, Wanqing Wen, Zhishan Chen, Yunjing Zhang, Ran Tao, Guochong Jia et al. · 2024 · Cancer Research
  72. cAMP-Dependent Protein Kinase A (PKA)–Mediated c-Myc Degradation Is Dependent on the Relative Proportion of PKA-I and PKA-II Isozymes
    Qingyuan Liu, Éric Nguyen, Stein Ove Døskeland, Évelyne Ségal-Bendirdjian · 2015 · Molecular Pharmacology
  73. Unbiased transcriptome mapping and modeling identify candidate genes and compounds of osteoarthritis
    Hui Cao, Yifan Fu, Zhenzhen Zhang, Weichun Guo · 2022 · Frontiers in Pharmacology
  74. The “LINC” between Δ40p53-miRNA Axis in the Regulation of Cellular Homeostasis
    Apala Pal, Pritam Kumar Ghosh, Saumitra Das · 2023 · Molecular and Cellular Biology
  75. Conferone, a coumarin from Ferula flabelliloba , induced toxic effects on adult T-cell leukemia/lymphoma cells
    Houshang Rafatpanah, Marziyeh Golizadeh, Maryam Mahdifar, Shakiba Mahdavi, Mehrdad Iranshahi, Fatemeh Behnam Rassouli · 2023 · International Journal of Immunopathology and Pharmacology
  76. Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression
    Zhe Hong, Chengdang Xu, Shengfeng Zheng, Xinan Wang, Yiran Tao, Yao Tan, Guowen Lin, Denglong Wu, Dingwei Ye · 2023 · Cell Death Discovery
  77. Reciprocal regulation of lncRNA MEF and c-Myc drives colorectal cancer tumorigenesis
    Shuang Wu, Xiangyu Dai, Zhipu Zhu, Dianhui Fan, Su Jiang, Yi Dong, Bing Chen, Qi Xie, Zhihui Yao, Qun Li et al. · 2024 · Neoplasia
  78. Alleviation of doxorubicin adverse effects via loading into various drug-delivery systems: a comparative study
    Rehab M. Abdel Megeed, Hassan Z. Ghanem, Mai O. Kadry · 2024 · Therapeutic Delivery
  79. Cancer Metabolism and Its Therapeutic Implications
    Weiqin Lu Craig D Logsdon, James L. Abbruzzese · 2013 · Journal of Cell Science & Therapy
  80. Molecular cloning and functional characterization of MYC transcription factor in pathogen-challenged Apostichopus japonicus
    Yi Zhang, Yina Shao, Zhimeng Lv, Weiwei Zhang, Xuelin Zhao, Ming Zhou Guo, Chenghua Li · 2019 · Developmental & Comparative Immunology
  81. Epigenetic Mechanisms of Ischemic Stroke
    Anatoly B. Uzdensky, Svetlana Viktorovna Demyanenko · 2019 · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology
  82. Role of the Mevalonate Pathway in Tocotrienol-Mediated Tumor Suppression
    Charles E. Elson, Huanbiao Mo · 2008 · CRC Press eBooks
  83. Correction: Discovery of a Natural Product-Like c-myc G-Quadruplex DNA Groove-Binder by Molecular Docking
    Dik‐Lung Ma, Daniel Shiu‐Hin Chan, Wai Chung Fu, Hong‐Zhang He, Hui Yang, Siu‐Cheong Yan, Chung‐Hang Leung · 2012 · PLoS ONE
  84. MG149 suppresses anaplastic thyroid cancer progression by inhibition of lysine acetyltransferase KAT5-mediated c-Myc acetylation
    Sheng Pan, Zhen Chen, Junjun Wen, Chuanming Tong, Ju Wang, Zhenning Du · 2024 · Bulletin du Cancer
  85. Identification of microbial metabolites that accelerate the ubiquitin-dependent degradation of c-Myc
    Z. L. Liu, Akiko Okano, Emiko Sanada, Yushi Futamura, Toshihiko Nogawa, Kosuke Ishikawa, Kentaro Semba, Jiang Li, Xiaomeng Li, Hiroyuki Osada et al. · 2023 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  86. ANP32B inhibition suppresses the growth of prostate cancer cells by regulating c-Myc signaling
    Cheng Zhou, Hangbin Ma, Wandong Yu, Yinghao Zhou, Xuehu Zhang, Yibo Meng, Chenchen Chen, Jun Zhang, Guowei Shi · 2024 · Biochemical and Biophysical Research Communications
  87. MYC dependency in GLS1 and NAMPT is a therapeutic vulnerability in multiple myeloma
    Lama Hasan Bou Issa, Léa Fléchon, William Laine, Aïcha Ouelkdite, Silvia Gaggero, Adeline Cozzani, Rémi Tilmont, Paul Chauvet, Nicolas Gower, Romanos Sklavenitis‐Pistofidis et al. · 2024 · iScience
  88. Temporal myc dynamics permit mitotic bypass, promoting polyploid phenotypes
    Michael A. Loycano, Kenneth J. Pienta, Sarah R. Amend · 2025 · Cancer Letters
  89. Cancer mutation profiles predict ICIs efficacy in patients with non-small cell lung cancer
    Liping Zhu, Dafu Ye, Tianyu Lei, Jie Wu, Wei Wang, Bin Xu · 2022 · Expert Reviews in Molecular Medicine
  90. Sorafenib decreases glycemia by impairing hepatic glucose metabolism
    Jingjing Ma, Fang Sui, Yan Liu, Mengmeng Yuan, Hui Dang, Rui Liu, Bingyin Shi, Peng Hou · 2022 · Endocrine
  91. Comparative- and network-based proteomic analysis of bacterial chondronecrosis with osteomyelitis lesions in broiler’s proximal tibiae identifies new molecular signatures of lameness
    Jennifer L. Cook, Elizabeth S. Greene, Alison Ramser, G.J. Mullenix, Jalila S. Dridi, Rohana Liyanage, Robert F. Wideman Jr., Sami Dridi · 2023 · Scientific Reports
  92. SERPINB3 in fibrogenic chronic liver diseases and primary liver cancers
    Patrizia Pontisso, Maurizio Parola · 2024 · Exploration of Digestive Diseases
  93. ACAT1 promotes proliferation and metastasis of bladder cancer via AKT/GSK3β/c-Myc signaling pathway
    Tingjun Wang, Gang Wang, Danni Shan, Yayun Fang, Fenfang Zhou, Meng-xue Yu, Lingao Ju, Gang Li, Wan Xiang, Kaiyu Qian et al. · 2024 · Journal of Cancer
  94. Missense Mutations in Myc Box I Influence Nucleocytoplasmic Transport to Promote Leukemogenesis
    Nancy B.J. Arthur, Keegan A. Christensen, Kathleen Mannino, Marianna B. Ruzinova, Ashutosh Kumar, Agata Gruszczyńska, Ryan B. Day, Petra Erdmann-Gilmore, Yiling Mi, Robert W. Sprung et al. · 2024 · Clinical Cancer Research
  95. Nilotinib: Disrupting the MYC-MAX Heterocomplex
    Kamilla Shah, Maham Ansari, Samina Saeed, Abdul Wali, Muhammad Mushtaq · 2024 · Bioinformatics and Biology Insights
  96. A cellular genetics approach identifies gene-drug interactions and pinpoints drug toxicity pathway nodes
    Oscar Suzuki, Amber Frick, Bethany Parks, O. Joseph Trask, Natasha Butz, Brian M. Steffy, Emmanuel Chan, David Scoville, Eric Healy, Cristina S. Benton et al. · 2014 · Frontiers in Genetics
  97. More, More, More: Downregulation of a MK5-FoxO3a-mir34b/c Pathway Further Increases c-Myc Levels in Colorectal Cancer
    Kevin Myant, Owen James Sansom · 2011 · Molecular Cell
  98. Shortening the list of essential genes in the human genome by network analysis
    Rasoul Godini, Hossein Fallahi · 2018 · Meta Gene
  99. RAB3D/MDM2/β-catenin/c-MYC axis exacerbates the malignant behaviors of acute myeloid leukemia cells in vitro and in vivo
    Jian Liu, Yumiao Mai, Yingjie Wang, Zhiwei Chen, Fei Wang, Huixia Wei, Qianghua Yao · 2022 · Cancer Gene Therapy
  100. Five Important Advances in Hematopathology
    Min Shi, Ruobing Xiao, Bruce A. Woda, Hongbo Yu · 2014 · Archives of Pathology & Laboratory Medicine